Aptevo Therapeutics Inc.
USD4.55
+0.00 (+0.00%)
CEO
Jeffrey G. Lamothe
IPO Date
2016-07-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.62
Prev. Close
$4.55
Day Low
$4.51
Day High
$4.71
52W Low
$3.80
52W High
$59.40
Market Cap
$0.01B
Volume
0.01M
| $8.00 |
| 28 May 2026 | Janatpour Mary Jo | SVP, CSO | Disposed | 0 | $0.00 |
| 12 Nov 2025 | Grant Grady III | director | P-Purchase | Acquired | 13,513 | $1.49 |
| 3 Oct 2025 | BANK OF AMERICA CORP /DE/ | 10 percent owner: | Disposed | 0 | $0.00 |
| 3 Oct 2025 | BANK OF AMERICA CORP /DE/ | 10 percent owner | Disposed | 0 | $0.00 |
| 8 Aug 2025 | Abdun-Nabi Daniel | director | A-Award | Acquired | 7,200 | $0.00 |
| 8 Aug 2025 | Taylor Daphne | SVP, CFO | A-Award | Acquired | 11,500 | $0.00 |
| 8 Aug 2025 | Grant Grady III | director | A-Award | Acquired | 7,200 | $0.00 |
| 8 Aug 2025 | Huebner Dirk | SVP, CMO | A-Award | Acquired | 11,500 | $0.00 |